HBsAg seroclearance reduces the risk of late recurrence in HBV-related HCC. Jin B, Du S, Yang H. J Hepatol 2022;77:1469-1470.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Jin B, Du S, Yang H. HBsAg seroclearance reduces the risk of late recurrence in HBV-related HCC. J Hepatol 2022;77:1469-1470.
PMID: 35810929